These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30582730)

  • 21. Immune reconstitution syndrome associated with leprosy: two cases.
    Deps PD; Gripp CG; Madureira BP; Lucas EA
    Int J STD AIDS; 2008 Feb; 19(2):135-6. PubMed ID: 18334074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus and leprosy--type 1 reactions, nerve damage and steroid therapy: 'a case report'.
    Bwire R; Kawuma HJ
    Lepr Rev; 1993 Sep; 64(3):267-9. PubMed ID: 8231607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial extensively drug-resistant tuberculosis in an HIV-infected child: a case report and review of literature.
    Uppuluri R; Shah I
    J Int Assoc Provid AIDS Care; 2014; 13(2):117-9. PubMed ID: 24401768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leprosy in the UK.
    Bharucha T; Lockwood D
    Br J Hosp Med (Lond); 2016 Oct; 77(10):C154-C156. PubMed ID: 27723400
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune reconstitution inflammatory syndrome associated with HIV and leprosy.
    Couppié P; Abel S; Voinchet H; Roussel M; Hélénon R; Huerre M; Sainte-Marie D; Cabié A
    Arch Dermatol; 2004 Aug; 140(8):997-1000. PubMed ID: 15313818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug packaging: what can TB learn from leprosy control?
    Kalk A; König J; van Wijnen A; Wiegandt A
    Int J Tuberc Lung Dis; 2003 Dec; 7(12):1211. PubMed ID: 14677900
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy of the mycobacterial diseases--leprosy and tuberculosis.
    Krenzien HN
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):223-32. PubMed ID: 6762341
    [No Abstract]   [Full Text] [Related]  

  • 28. An update on the diagnosis and treatment of leprosy.
    Moschella SL
    J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus and leprosy: an update.
    Lockwood DN; Lambert SM
    Dermatol Clin; 2011 Jan; 29(1):125-8. PubMed ID: 21095536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of leprosy with rifampicin and isoprodian (L73A).
    Terencio de las Aguas J
    Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: Problems and opportunities in the therapy of leprosy.
    Jopling WH
    Lepr Rev; 1974 Dec; 45(4):285-7. PubMed ID: 4444391
    [No Abstract]   [Full Text] [Related]  

  • 33. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical rash.
    Cataño JC; Giraldo DE
    Eur J Intern Med; 2019 May; 63():e5-e6. PubMed ID: 30593444
    [No Abstract]   [Full Text] [Related]  

  • 35. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
    Lockwood DN
    Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
    [No Abstract]   [Full Text] [Related]  

  • 37. Response to 'Elimination of leprosy in India: An analysis'.
    Kumar B
    Indian J Dermatol Venereol Leprol; 2018; 84(4):443-444. PubMed ID: 29893302
    [No Abstract]   [Full Text] [Related]  

  • 38. Priorities for the future and prospects for leprosy control.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):82-101. PubMed ID: 8326185
    [No Abstract]   [Full Text] [Related]  

  • 39. Leprosy as immune reconstitution inflammatory syndrome in patients living with HIV: Description of French Guiana's cases over 20 years and systematic review of the literature.
    Mouchard A; Blaizot R; Graille J; Couppié P; Bertin C
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010239. PubMed ID: 35245291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.